(-)-anisomycin increases phosphorylation ISO AGO2 (Homo sapiens) 6480464 Anisomycin results in increased phosphorylation of AGO2 protein CTD PMID:18476811 (-)-demecolcine decreases expression ISO AGO2 (Homo sapiens) 6480464 Demecolcine results in decreased expression of AGO2 mRNA CTD PMID:23649840 1,2-dimethylhydrazine multiple interactions ISO Ago2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGO2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO Ago2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of AGO2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of AGO2 mRNA CTD PMID:29097150 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of AGO2 mRNA CTD PMID:20068009 17beta-estradiol increases expression ISO AGO2 (Homo sapiens) 6480464 Estradiol results in increased expression of AGO2 mRNA CTD PMID:23019147 and PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ago2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AGO2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AGO2 mRNA CTD PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of AGO2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO AGO2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AGO2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO AGO2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of AGO2 mRNA CTD PMID:21179406 2-palmitoylglycerol increases expression ISO AGO2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AGO2 mRNA CTD PMID:37199045 3,4-methylenedioxymethamphetamine increases expression ISO Ago2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of AGO2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO2 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AGO2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO Ago2 (Mus musculus) 6480464 bisphenol S affects the methylation of AGO2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO AGO2 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of AGO2 gene CTD PMID:31601247 4-hydroxynon-2-enal decreases expression ISO Ago2 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of AGO2 mRNA CTD PMID:19191707 5-chloro-7-iodoquinolin-8-ol multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 mRNA and [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 protein CTD PMID:22415087 7,12-dimethyltetraphene increases expression ISO Ago2 (Mus musculus) 6480464 9 more ... CTD PMID:24792773 7,12-dimethyltetraphene multiple interactions ISO Ago2 (Mus musculus) 6480464 Butyric Acid affects the reaction [9 more ... CTD PMID:24792773 acrolein multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGO2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGO2 mRNA CTD PMID:32699268 alachlor increases expression EXP 6480464 alachlor results in increased expression of AGO2 mRNA CTD PMID:12419858 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of AGO2 mRNA CTD PMID:24977338 all-trans-retinoic acid decreases expression ISO AGO2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of AGO2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGO2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGO2 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO AGO2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of AGO2 mRNA CTD PMID:33212167 arsane affects methylation ISO AGO2 (Homo sapiens) 6480464 Arsenic affects the methylation of AGO2 gene CTD PMID:25304211 and PMID:32603190 arsane multiple interactions ISO AGO2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AGO2 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO AGO2 (Homo sapiens) 6480464 Arsenic affects the methylation of AGO2 gene CTD PMID:25304211 and PMID:32603190 arsenic atom multiple interactions ISO AGO2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AGO2 mRNA CTD PMID:32525701 arsenous acid decreases expression ISO AGO2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of AGO2 protein CTD PMID:25419056 arsenous acid multiple interactions ISO AGO2 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [AGO2 protein binds to SESN2 mRNA] CTD PMID:29662624 benzo[a]pyrene multiple interactions ISO Ago2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO AGO2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 benzo[b]fluoranthene multiple interactions ISO Ago2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO AGO2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of AGO2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AGO2 mRNA CTD PMID:25181051 bisphenol A affects methylation ISO AGO2 (Homo sapiens) 6480464 bisphenol A affects the methylation of AGO2 gene CTD PMID:31601247 bisphenol A decreases expression ISO Ago2 (Mus musculus) 6480464 bisphenol A results in decreased expression of AGO2 mRNA CTD PMID:37761913 and PMID:38074096 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AGO2 mRNA CTD PMID:29097150 bisphenol A multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO2 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AGO2 mRNA CTD PMID:28628672 butyric acid multiple interactions ISO Ago2 (Mus musculus) 6480464 Butyric Acid affects the reaction [9 more ... CTD PMID:24792773 caffeine increases phosphorylation ISO AGO2 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of AGO2 protein CTD PMID:35688186 calcitriol increases expression ISO AGO2 (Homo sapiens) 6480464 Calcitriol results in increased expression of AGO2 mRNA CTD PMID:16002434 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [PICK1 protein binds to AGO2 protein] and Calcium deficiency inhibits the reaction [Excitatory Amino Acid Agonists inhibits the reaction [PICK1 protein binds to AGO2 protein]] CTD PMID:28404816 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [PICK1 protein binds to AGO2 protein] and Calcium deficiency inhibits the reaction [Excitatory Amino Acid Agonists inhibits the reaction [PICK1 protein binds to AGO2 protein]] CTD PMID:28404816 carbamazepine affects expression ISO AGO2 (Homo sapiens) 6480464 Carbamazepine affects the expression of AGO2 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO Ago2 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of AGO2 mRNA CTD PMID:25554681 cerium trichloride increases expression ISO Ago2 (Mus musculus) 6480464 cerous chloride results in increased expression of AGO2 mRNA CTD PMID:23573234 CGP 52608 multiple interactions ISO AGO2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to AGO2 gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of AGO2 mRNA CTD PMID:23125180 chrysene multiple interactions ISO Ago2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of AGO2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO AGO2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of AGO2 mRNA CTD PMID:27392435 and PMID:27594783 cocaine multiple interactions ISO Ago2 (Mus musculus) 6480464 AGO2 protein affects the reaction [Cocaine results in increased expression of MIR130A mRNA] more ... CTD PMID:20643829 cocaine affects response to substance ISO Ago2 (Mus musculus) 6480464 AGO2 protein affects the susceptibility to Cocaine CTD PMID:20643829 copper(II) sulfate increases expression ISO AGO2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of AGO2 mRNA CTD PMID:19549813 coumestrol decreases expression ISO AGO2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of AGO2 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO Ago2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of AGO2 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO AGO2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of AGO2 mRNA CTD PMID:20106945 and PMID:25562108 dexamethasone multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO2 mRNA more ... CTD PMID:28628672 diarsenic trioxide decreases expression ISO AGO2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of AGO2 protein CTD PMID:25419056 diarsenic trioxide multiple interactions ISO AGO2 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [AGO2 protein binds to SESN2 mRNA] CTD PMID:29662624 diazinon increases methylation ISO AGO2 (Homo sapiens) 6480464 Diazinon results in increased methylation of AGO2 gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of AGO2 mRNA CTD PMID:21266533 diclofenac affects expression ISO AGO2 (Homo sapiens) 6480464 Diclofenac affects the expression of AGO2 mRNA CTD PMID:24752500 dicrotophos increases expression ISO AGO2 (Homo sapiens) 6480464 dicrotophos results in increased expression of AGO2 mRNA CTD PMID:28302478 diethylstilbestrol decreases expression ISO AGO2 (Homo sapiens) 6480464 Diethylstilbestrol results in decreased expression of AGO2 mRNA CTD PMID:36621641 dioxygen multiple interactions ISO Ago2 (Mus musculus) 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of AGO2 mRNA] CTD PMID:22629407 dioxygen increases expression ISO Ago2 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of AGO2 mRNA CTD PMID:22629407 dorsomorphin multiple interactions ISO AGO2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGO2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO AGO2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of AGO2 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of AGO2 mRNA CTD PMID:29391264 ethanol increases expression ISO Ago2 (Mus musculus) 6480464 Ethanol results in increased expression of AGO2 mRNA CTD PMID:30319688 excitatory amino acid agonist multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [Excitatory Amino Acid Agonists inhibits the reaction [PICK1 protein binds to AGO2 protein]] and Excitatory Amino Acid Agonists inhibits the reaction [PICK1 protein binds to AGO2 protein] CTD PMID:28404816 fenthion decreases expression ISO Ago2 (Mus musculus) 6480464 Fenthion results in decreased expression of AGO2 mRNA CTD PMID:34813904 fipronil increases expression EXP 6480464 fipronil results in increased expression of AGO2 mRNA CTD PMID:34044035 folic acid multiple interactions ISO Ago2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGO2 mRNA CTD PMID:22206623 folic acid decreases expression ISO Ago2 (Mus musculus) 6480464 Folic Acid results in decreased expression of AGO2 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO AGO2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of AGO2 mRNA CTD PMID:20655997 FR900359 decreases phosphorylation ISO AGO2 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of AGO2 protein CTD PMID:37730182 fulvestrant increases methylation ISO AGO2 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of AGO2 gene CTD PMID:31601247 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of AGO2 mRNA CTD PMID:33387578 glucaric acid multiple interactions ISO Ago2 (Mus musculus) 6480464 Glucaric Acid affects the reaction [9 more ... CTD PMID:24792773 indometacin multiple interactions ISO AGO2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO2 mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO AGO2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of AGO2 protein CTD PMID:32959892 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of AGO2 mRNA CTD PMID:15372504 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of AGO2 mRNA CTD PMID:16507785 methapyrilene decreases methylation ISO AGO2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of AGO2 intron CTD PMID:30157460 methidathion decreases expression ISO Ago2 (Mus musculus) 6480464 methidathion results in decreased expression of AGO2 mRNA CTD PMID:34813904 methylmercury chloride increases expression ISO AGO2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of AGO2 mRNA CTD PMID:23179753 and PMID:26272509 methylmercury chloride multiple interactions ISO AGO2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGO2 mRNA CTD PMID:27188386 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AGO2 gene CTD PMID:33148267 nickel atom increases expression ISO AGO2 (Homo sapiens) 6480464 Nickel results in increased expression of AGO2 mRNA CTD PMID:25583101 nicotinamide multiple interactions ISO Ago2 (Mus musculus) 6480464 Niacinamide affects the reaction [9 more ... CTD PMID:24792773 ozone multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGO2 mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol affects expression ISO Ago2 (Mus musculus) 6480464 Acetaminophen affects the expression of AGO2 mRNA CTD PMID:17562736 paracetamol increases expression ISO AGO2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of AGO2 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO AGO2 (Homo sapiens) 6480464 Acetaminophen promotes the reaction [MIR122 mRNA binds to AGO2 protein] and Acetaminophen promotes the reaction [MIR885 mRNA binds to AGO2 protein] CTD PMID:26489516 perfluorohexanesulfonic acid decreases expression ISO Ago2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of AGO2 mRNA CTD PMID:37995155 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AGO2 gene CTD PMID:33148267 phenobarbital affects expression ISO AGO2 (Homo sapiens) 6480464 Phenobarbital affects the expression of AGO2 mRNA CTD PMID:19159669 phenobarbital affects expression ISO Ago2 (Mus musculus) 6480464 Phenobarbital affects the expression of AGO2 mRNA CTD PMID:23091169 quercetin increases expression ISO AGO2 (Homo sapiens) 6480464 Quercetin results in increased expression of AGO2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO AGO2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AGO2 mRNA CTD PMID:30851411 raloxifene affects expression ISO AGO2 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of AGO2 mRNA CTD PMID:14699072 raloxifene multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of AGO2 mRNA CTD PMID:19059307 rotenone decreases expression ISO Ago2 (Mus musculus) 6480464 Rotenone results in decreased expression of AGO2 mRNA CTD PMID:23186747 rotenone increases expression EXP 6480464 Rotenone results in increased expression of AGO2 mRNA CTD PMID:28374803 SB 203580 multiple interactions ISO AGO2 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased localization of AGO2 protein] CTD PMID:18476811 SB 431542 multiple interactions ISO AGO2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGO2 mRNA CTD PMID:27188386 silver atom affects expression ISO Ago2 (Mus musculus) 6480464 Silver affects the expression of AGO2 mRNA CTD PMID:27131904 silver(0) affects expression ISO Ago2 (Mus musculus) 6480464 Silver affects the expression of AGO2 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO AGO2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AGO2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO AGO2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AGO2 mRNA CTD PMID:21457566 sodium arsenite multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [AGO2 protein binds to TARBP2 protein] and sodium arsenite promotes the reaction [AGO2 protein binds to PRKCA protein] CTD PMID:30404558 sodium arsenite multiple interactions ISO AGO2 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased localization of AGO2 protein] more ... CTD PMID:18476811 more ... tamoxifen affects expression ISO AGO2 (Homo sapiens) 6480464 Tamoxifen affects the expression of AGO2 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of AGO2 mRNA CTD PMID:19059307 tert-butyl hydroperoxide increases expression ISO AGO2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of AGO2 mRNA CTD PMID:15336504 testosterone decreases expression ISO AGO2 (Homo sapiens) 6480464 Testosterone results in decreased expression of AGO2 mRNA CTD PMID:33359661 tetrachloromethane increases expression ISO Ago2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of AGO2 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of AGO2 mRNA CTD PMID:31150632 tetraphene multiple interactions ISO Ago2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AGO2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO Ago2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of AGO2 mRNA CTD PMID:23557971 troglitazone decreases expression ISO Ago2 (Mus musculus) 6480464 troglitazone results in decreased expression of AGO2 mRNA CTD PMID:28973697 tungsten decreases expression ISO Ago2 (Mus musculus) 6480464 Tungsten results in decreased expression of AGO2 mRNA CTD PMID:30912803 valproic acid decreases expression ISO AGO2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AGO2 mRNA CTD PMID:23179753 and PMID:28001369 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of AGO2 mRNA CTD PMID:29427782 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of AGO2 mRNA CTD PMID:25423262 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of AGO2 mRNA CTD PMID:18042343 and PMID:23034163 vorinostat decreases expression ISO AGO2 (Homo sapiens) 6480464 vorinostat results in decreased expression of AGO2 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO AGO2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of AGO2 mRNA CTD PMID:18593933 zinc dichloride multiple interactions ISO AGO2 (Homo sapiens) 6480464 [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 mRNA and [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 protein CTD PMID:22415087 zinc(0) multiple interactions ISO AGO2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of AGO2 mRNA CTD PMID:18593933